Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer.

Andrew Brenner(The University of Texas at San Antonio Health Science Center), C. Marcelo Aldaz(The University of Texas MD Anderson Cancer Center), Martin Dreyling(LMU Klinikum), Olufunmilayo I. Olopade(University of Chicago), Abhaya Paladugu(The University of Texas MD Anderson Cancer Center), Hui Wang(Tibet Autonomous Region People's Hospital)
PubMed
December 1, 1996
Cited by 59


Related Papers